We are looking for adults (21+) to participate in a one-time, in person eye-tracking appointment to help us understand how people view health messages. An eye tracker is a small camera attached to a laptop that can record where on a screen a person is looking.

This study aims to investigate the effectiveness and safety of retatrutide, a new diabetes medication) at doses of 4 mg, 9 mg, or 12 mg that will be taken as a weekly injection for about 1 year, compared to a placebo. A participant's change in HbA1c level will be primary outcome of interest. We are seeking participants with type 2 diabetes that has affected kidney function and are currently taking long-acting insulin with metformin and/or a SGLT2 inhibitor.

To understand the views and perceptions of Ugandan social work academics who utilize decolonial and indigenous theories and practices, including ubuntu, in their work.

Are you dealing with multiple myeloma that keeps coming back or hasn't improved? If you are, you may be able to join a study to see if a new drug called ABBV-383 could be safe and helpful for people in your situation. You will be reimbursed for travel expenses. You will not have to pay for the drug while you take part in this study.

We are conducting interviews with members of the community to understand their perceptions related to mold in the home, and to capture any behaviors and concerns they have about mold.

Have you been diagnosed with Chronic Lymphocytic Leukemia (CLL) that has transformed to aggressive lymphoma called Richter's Transformation (RT)? Then you may be able to participate in this study whose purpose is to evaluate the efficacy and safety of glofitamab as monotherapy and in combination with polatuzumab vedotin or atezolizumab for participants with Richter's Transformation (RT) that has transformed from chronic lymphocytic leukemia (CLL). These are targeted immune-based therapies standardly used to treat lymphoma and/or other cancers that may also work well for RT

In this study, we want to improve virtual healthcare by seeking feedback from those who have used virtual care (ex. telehealth, or e-visits). We are looking for patients, administrators, providers or policymakers to provide feedback through individual, private interviews. Your perspective will help us to foster equitable and sustainable virtual care solutions.

In this study, we want to learn how people find and understand information. We want to see how this information affects their lives and their thoughts on money.

Do you have ovarian, peritoneal, or fallopian tube cancer that came back after receiving standard therapy? If so, you might be able to take part in a study that looks at a new treatment, iC9.CAR.B7-H3 cells, to test the safety of these cells and observe any side effects.

The purpose of this study is to understand if a new oral medication (pill) can be used to treat depression in people who have not felt relief from other anti-depression medications.